Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Apolone

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 1, 1995
A European project assessing the appropriateness of hospital utilization: background, objectives and preliminary results. The Project Steering Group and the Coordinating CenterA Liberati, G Apolone, T Lang, et al.
Therapeutics and Clinical Risk Management|September 24, 2009
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic reviewS Deandrea, O Corli, I Moschetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Prevalence of undertreatment in cancer pain. A review of published literatureS Deandrea, M Montanari, L Moja, et al.
Critical Care Medicine|August 26, 1998
Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care unitsG Bertolini, D Ripamonti, A Cattaneo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2008
Factors influencing the decision to take or reject opioids for cancer pain: are we on target?G Apolone, O Corli, M T Greco, et al.
Pharmacoeconomics|April 4, 2001
Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approvalG Apolone, G De Carli, M Brunetti, et al.
Medical Care|February 1, 1993
The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacementS Greenfield, G Apolone, B J McNeil, et al.
Minerva Anestesiologica|March 1, 1996
[Evaluation of activity in intensive care. A comparison of administrative and epidemiologic data]F Repetto, P Federico, A Cattaneo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Does a drug do better when it is new?R Fossati, C Confalonieri, G Apolone, et al.
Minerva Dietologica E Gastroenterologica|July 1, 1986
[Somatostatin in the treatment of upper digestive hemorrhage. Experience and controversy]G Apolone, A Raina, C Gili, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 1, 1995
A European project assessing the appropriateness of hospital utilization: background, objectives and preliminary results. The Project Steering Group and the Coordinating CenterA Liberati, G Apolone, T Lang, et al.
Therapeutics and Clinical Risk Management|September 24, 2009
Managing severe cancer pain: the role of transdermal buprenorphine: a systematic reviewS Deandrea, O Corli, I Moschetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Prevalence of undertreatment in cancer pain. A review of published literatureS Deandrea, M Montanari, L Moja, et al.
Critical Care Medicine|August 26, 1998
Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care unitsG Bertolini, D Ripamonti, A Cattaneo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2008
Factors influencing the decision to take or reject opioids for cancer pain: are we on target?G Apolone, O Corli, M T Greco, et al.
Pharmacoeconomics|April 4, 2001
Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approvalG Apolone, G De Carli, M Brunetti, et al.
Medical Care|February 1, 1993
The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacementS Greenfield, G Apolone, B J McNeil, et al.
Minerva Anestesiologica|March 1, 1996
[Evaluation of activity in intensive care. A comparison of administrative and epidemiologic data]F Repetto, P Federico, A Cattaneo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Does a drug do better when it is new?R Fossati, C Confalonieri, G Apolone, et al.
Minerva Dietologica E Gastroenterologica|July 1, 1986
[Somatostatin in the treatment of upper digestive hemorrhage. Experience and controversy]G Apolone, A Raina, C Gili, et al.
Pageof 11